Add BrightSurf on Google Email

Seeing progress

Scientists have created a model that replicates the progression of age-related macular degeneration (AMD), a disease with no current treatment. By understanding how RPE cells respond to stress and changes in gene expression, researchers can now test potential therapeutics for dry AMD.

The mystery of visual stability

A study by Tohoku University's Research Institute of Electrical Communication reveals that visual stability across saccades occurs when parvo-pathway signals suppress magno-pathway signals immediately after a saccade. This finding has implications for AI and robots to perceive the world as humans do.

SourceTohoku University·JournalScientific Reports·DateJun 11, 2020

A vitamin A analog may help treat diabetic retinopathy

A new study published in the American Journal of Pathology reports that a single dose of visual chromophore 9-cis-retinal improves visual function in diabetic mice by reducing oxidative stress and cell death. This treatment may represent a potential therapy for early diabetic retinopathy.

SourceElsevier·JournalAmerican Journal Of Pathology·DateJun 11, 2020

Inexpensive retinal diagnostics via smartphone

A study by the University of Bonn shows that smartphone-based fundus imaging can detect diabetic retinopathy with high accuracy, even in early stages. The method allows for efficient screening and diagnosis, enabling trained laypersons to examine patients, reducing hospital visits.

SourceUniversity of Bonn·JournalOphthalmology·DateMay 25, 2020

Tetracycline-family antibiotics may offer early diagnostic for degenerative eye disease

Researchers discovered a potential new method to detect age-related macular degeneration using tetracycline staining and fluorescence lifetime imaging microscopy. Tiny deposits of lipids, proteins, and minerals under the retina can be visualized with this technique, offering enhanced early detection.

SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateApr 21, 2020

CNIC scientists identify an immunological regulatory circuit that may play a central role in ocular diseases

Researchers at CNIC have identified an inflammatory regulatory circuit controlled by endothelial cells in the eye, which may regulate retinal vascular diseases and inflammatory disorders. The discovery provides new perspectives on treating conditions like age-related macular degeneration (AMD).

Ultra-wide field retinal imaging techniques cannot be used interchangeably

A new study from the Joslin Diabetes Center reveals that ultra-wide field (UWF) fluorescein angiography detects over three times more microaneurysms than UWF color imaging, highlighting the need for cautious use of these techniques when evaluating and treating diabetic retinopathy. The research also suggests that AI can automate the gr...

SourceJoslin Diabetes Center·JournalBritish Journal of Ophthalmology·DateMar 5, 2020

Light at the end of the tunnel for most individuals with low-vision

A special issue of Restorative Neurology and Neuroscience reports remarkable progress in treating conditions of partial blindness. Research explores various aspects of vision loss due to diseases like glaucoma or optic neuropathy, with a focus on stop-cell death and induce regeneration to restore vision.

SourceIOS Press·JournalRestorative Neurology and Neuroscience·DateJan 22, 2020

Oxygen shaped the evolution of the eye

Researchers discovered a pattern of mechanisms improving retinal oxygen supply that evolved with enhanced vision in all bony vertebrates. The findings add to our understanding of the evolution of the eye, highlighting its dynamic morphology and relationship with retinal oxygen supply.

Johns Hopkins researchers advance search for safer, easier way to deliver vision-saving gene therapy

Researchers have developed a new approach to delivering sight-saving gene therapy to the retina, using a small needle to inject harmless viruses into the suprachoroidal space. This method could provide a more permanent therapeutic option for patients with common diseases such as wet age-related macular degeneration and inherited retina...

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateSep 30, 2019

Researchers have identified areas of the retina that change in mild Alzheimer's disease

Researchers at the Complutense University of Madrid have identified areas of the retina that change in patients with mild Alzheimer's disease. The study used optical coherence tomography to measure retinal layer thickness and found significant thinning in certain locations, which can be used to diagnose the disease before other tests.

SourceUniversidad Complutense de Madrid·JournalScientific Reports·DateSep 13, 2019

Genetic discovery linked to rare eye disease, MacTel

Researchers at the University of Utah Health have made a groundbreaking genetic discovery linking MacTel to HSAN1, revealing that toxic biomolecules deoxySLs cause damage to the macula. The study also found that lipid-lowering medication fenofibrate shows potential in protecting the retina from these biomolecules.

SourceUniversity of Utah Health·JournalNew England Journal of Medicine·DateSep 11, 2019

The birth of vision, from the retina to the brain

Researchers at UNIGE identified key genes regulating retinal cell differentiation and axon guidance, offering insights into the construction of vision and potential treatments for neurodegenerative diseases. The study's findings have significant implications for regenerative medicine and could lead to new therapies for optic nerve damage.

SourceUniversité de Genève·JournalDevelopment·DateSep 9, 2019

Retina-on-a-chip provides powerful tool for studying eye disease

Scientists have developed a retina-on-a-chip technology that recreates the human retina's complex tissue architecture, enabling the efficient study of eye diseases and screening for drug side effects. The tool uses living human cells with an artificial tissue-like system, mimicking the body's environment and blood vessels.

SourceeLife·DateAug 27, 2019

Finding a cell's true identity

Researchers developed two AI methods that decipher complex gene activity controlling cell fate decisions in retina development, relating this gene activity to other tissues and across different species. The findings provide key insights into human disease and highlight the potential for AI to shed light on cancer treatment.

SourceJohns Hopkins Medicine·JournalCell Systems·DateMay 28, 2019

Eye's vulnerability to macular degeneration revealed

Scientists discovered differences in Müller cell shape and biology between the retina's macula and peripheral regions, shedding light on the eye's defense mechanism against disease. The study found that macula Müller cells produce more serine, a protective amino acid, but are more susceptible to stress when this production is blocked.

SourceeLife·DateMay 7, 2019